Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter Pylori CagA and gastric cancer risk

Gut Microbes

Volumn 3, Issue 1, 2012, Pages 48-56

  Chaturvedi, Rupesh ^a,b   de Sablet, Thibaut ^a,b   Peek, Richard M ^a,b,c   Wilson, Keith T ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Veterans Affairs   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; DNA damage; Epithelial cells; Helicobacter pylori; Hydrogen peroxide; Infection; Oxidative stress; Polyamines; Stomach

Indexed keywords

CAGA PROTEIN; CASPASE 3; EFLORNITHINE; GAMMA INTERFERON; MESSENGER RNA; N,N' BIS(2,3 BUTADIENYL)PUTRESCINE; OXIDOREDUCTASE; POLYAMINE OXIDASE; REACTIVE OXYGEN METABOLITE; SPERMIDINE; SPERMINE OXIDASE; UNCLASSIFIED DRUG; VASCULOTROPIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; HYDROGEN PEROXIDE; SPERMINE; VIRULENCE FACTOR;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CANCER RISK; CELL POPULATION; CYTOTOXICITY; DNA DAMAGE; ENZYME DEGRADATION; FLOW CYTOMETRY; GASTROINTESTINAL DYSPLASIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE EPITHELIUM CELL; MACROPHAGE; NEUTROPHIL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; POLYAMINE SYNTHESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; EPITHELIUM CELL; GERBIL; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY; REVIEW; STOMACH TUMOR;

ANIMALIA; GERBILLINAE; HELICOBACTER PYLORI; MUS;

ANIMALS; ANTIGENS, BACTERIAL; APOPTOSIS; BACTERIAL PROTEINS; DNA DAMAGE; EPITHELIAL CELLS; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN PEROXIDE; MICE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; SPERMINE; STOMACH NEOPLASMS; VIRULENCE FACTORS;

EID: 85046980953     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.19345     Document Type: Article

References (48)

1. Peek RM, Jr., Fiske C, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev 2010; 90:831-58; PMID: 20664074; http://dx.doi.org/10.1152/physrev.00039.2009
2. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007; 133:288-308; PMID:17631150; http://dx.doi.org/10.1053/j.gastro.2007.05.008
3. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8):S4-66; PMID:11602373; http://dx.doi.org/10.1016/S0959-8049(01)00267-2
4. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-31; PMID:1891020; http://dx.doi.org/10.1056/NEJM199110173251603
5. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010; 105:493-8; PMID:20203636; http://dx.doi.org/10.1038/ajg.2009.728
6. Polk DB, Peek RM, Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10: 403-14; PMID:20495574; http://dx.doi.org/10.1038/nrc2857
7. Chaturvedi R, de Sablet T, Coburn LA, Gobert AP, Wilson KT. Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids 2011. In press. PMID: 21874531; http://dx.doi.org/10.1007/s00726-011-1038-4
8. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003; 376: 1-14 PMID:13678416; http://dx.doi.org/10.1042/BJ20031327
9. Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J 2009; 421:323-38 PMID: 19589128; http://dx.doi.org/10.1042/BJ20090598
10. Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 2008; 294:E995-1010 PMID:18349109; http://dx.doi.org/10.1152/ajpendo.90217.2008
11. Uemura T, Yerushalmi HF, Tsaprailis G, Stringer DE, Pastorian KE, Hawel L, 3rd, et al. Identification and characterization of a diamine exporter in colon epithelial cells. J Biol Chem 2008; 283:26428-35 PMID: 18660501; http://dx.doi.org/10.1074/jbc.M804714200
12. Wang Y, Devereux W, Woster PM, Stewart TM, Hacker A, Casero RA, Jr. Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 2001; 61:5370-3 PMID:11454677
13. Vujcic S, Diegelman P, Bacchi CJ, Kramer DL, Porter CW. Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem J 2002; 367:665-75 PMID: 12141946; http://dx.doi.org/10.1042/BJ20020720
14. Murray-Stewart T, Wang Y, Devereux W, Casero RA, Jr. Cloning and characterization of multiple human polyamine oxidase splice variants that code for isoenzymes with different biochemical characteristics. Biochem J 2002; 368:673-7 PMID:12398765; http://dx.doi.org/10.1042/BJ20021587
15. Cervelli M, Polticelli F, Federico R, Mariottini P. Heterologous expression and characterization of mouse spermine oxidase. J Biol Chem 2003; 278: 5271-6 PMID:12458219; http://dx.doi.org/10.1074/jbc.M207888200
16. Murray-Stewart T, Wang Y, Goodwin A, Hacker A, Meeker A, Casero RA, Jr. Nuclear localization of human spermine oxidase isoforms possible implications in drug response and disease etiology. FEBS J 2008; 275:2795-806 PMID:18422650; http://dx.doi.org/10.1111/j.1742-4658.2008.06419.x
17. Bianchi M, Amendola R, Federico R, Polticelli F, Mariottini P. Two short protein domains are responsible for the nuclear localization of the mouse spermine oxidase mu isoform. FEBS J 2005; 272:3052-9 PMID:15955064; http://dx.doi.org/10.1111/j.1742-4658.2005.04718.x
18. Cervelli M, Bellini A, Bianchi M, Marcocci L, Nocera S, Polticelli F, et al. Mouse spermine oxidase gene splice variants. Nuclear subcellular localization of a novel active isoform. Eur J Biochem 2004; 271: 760-70 PMID:14764092; http://dx.doi.org/10.1111/j.1432-1033.2004.03979.x
19. Wang Y, Murray-Stewart T, Devereux W, Hacker A, Frydman B, Woster PM, et al. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem Biophys Res Commun 2003; 304:605-11 PMID:12727196; http://dx.doi.org/10.1016/S0006-291X(03)00636-3
20. Bellelli A, Cavallo S, Nicolini L, Cervelli M, Bianchi M, Mariottini P, et al. Mouse spermine oxidase: a model of the catalytic cycle and its inhibition by N,N1-bis(2,3-butadienyl)-1,4-butanediamine. Biochem Biophys Res Commun 2004; 322:1-8 PMID: 15313165; http://dx.doi.org/10.1016/j.bbrc.2004.07.074
21. Wang Y, Hacker A, Murray-Stewart T, Fleischer JG, Woster PM, Casero RA, Jr. Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein. Biochem J 2005; 386:543-7 PMID:15496143; http://dx.doi.org/10.1042/BJ20041084
22. Chaturvedi R, Cheng Y, Asim M, Bussière FI, Xu H, Gobert AP, et al. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem 2004; 279:40 161-73 PMID:15247269; http://dx.doi.org/10.1074/jbc.M401370200
23. Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, Yao MD, et al. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004; 64:8521-5 PMID:15574757; http://dx.doi.org/10.1158/0008-5472.CAN-04-3511.
24. Chaturvedi R, Asim M, Romero-Gallo J, Barry DP, Hoge S, de Sablet T, et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 2011; 141:1696-708. e1-2 PMID:21839041; http://dx.doi.org/10.1053/j. gastro.2011.07.045
25. Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28:37-53 PMID:9593295; http://dx.doi.org/10.1046/j.1365-2958.1998.00770.x
26. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and diseaseassociated virulence factors. Proc Natl Acad Sci U S A 1996; 93:14648-53 PMID:8962108; http://dx.doi. org/10.1073/pnas.93.25.14648
27. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5 PMID: 7743510
28. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter 2003; 8:227-34 PMID:12752735; http://dx.doi.org/10.1046/j.1523-5378.2003.00149.x
29. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A 2008; 105:1003-8 PMID:18192401; http://dx.doi.org/10.1073/pnas.0711183105
30. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci U S A 1993; 90:587-91 PMID:7678459; http://dx.doi.org/10.1073/pnas.90.2.587
31. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 2008; 68:379-87 PMID:18199531; http://dx.doi.org/10.1158/0008-5472.CAN-07-0824
32. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, et al. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 2011; 140:199-209 PMID: 20600031; http://dx.doi.org/10.1053/j.gastro.2010.06.047
33. Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003; 124:1408-19 PMID:12730880; http://dx.doi.org/10.1016/S0016-5085(03)00266-X
34. Saito Y, Murata-Kamiya N, Hirayama T, Ohba Y, Hatakeyama M. Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. J Exp Med 2010; 207:2157-74 PMID:20855497; http://dx.doi.org/10.1084/jem.20100602
35. Valenzuela M, Pérez-Pérez G, Corvalán AH, Carrasco G, Urra H, Bravo D, et al. Helicobacter pylori-induced loss of the inhibitor-of-apoptosis protein survivin is linked to gastritis and death of human gastric cells. J Infect Dis 2010; 202:1021-30 PMID:20735270;http://dx.doi.org/10.1086/656143
36. Wagner S, Beil W, Westermann J, Logan RP, Bock CT, Trautwein C, et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology 1997; 113: 1836-47 PMID:9394723; http://dx.doi.org/10.1016/S0016-5085(97)70003-9
37. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, et al. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology 2009; 136:1297-1307, e1-3 PMID:19250983; http://dx.doi.org/10.1053/j.gastro.2008.12.059
38. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011; 121:3088-93 PMID:21737881; http://dx.doi.org/10.1172/JCI45041
39. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198:553-60 PMID:18598192; http://dx.doi.org/10.1086/590158
40. Dellon ES, Peery AF, Shaheen NJ, Morgan DR, Hurrell JM, Lash RH, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology 2011; 141:1586-92 PMID:21762663; http://dx.doi.org/10.1053/j.gastro.2011.06.081
41. Koike T, Ohara S, Sekine H, Iijima K, Kato K, Shimosegawa T, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999; 94:3468-72 PMID: 10606305; http://dx.doi.org/10.1111/j.1572-0241.1999.01593.x.
42. Czinn SJ, Blanchard T. Vaccinating against Helicobacter infection. Nat Rev gastroenterol Hepatol 2011; 8: 133-40 PMID:21304478; http//dx.doi.org/10.1038/nrgastro.2011.1.
43. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 2009; 136:247-56 PMID:18948106; http://dx.doi.org/10.1053/j.gastro.2008.09.017
44. Arnold IC, Hitzler I, Engler D, Oertli M, Agger EM, Müller A. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia. J Immunol 2011; 186:6165-72 PMID:21518972; http://dx.doi.org/10.4049/jimmunol.1003472
45. Chaturvedi R, Asim M, Hoge S, Lewis ND, Singh K, Barry DP, et al. Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production. Gastroenterology 2010; 139:1686-98, 1698, e1-6 PMID:20600019; http://dx.doi.org/10.1053/j.gastro.2010.06.060
46. Barry DP, Asim M, Leiman DA, de Sablet T, Singh K, Casero RA, Jr., et al. Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS One 2011; 6:e17510 PMID:21386987; http://dx.doi.org/10.1371/journal.pone.0017510
47. Bey P, Bolkenius FN, Seiler N, Casara P. N-2,3-Butadienyl-1,4-butanediamine derivatives: potent irreversible inactivators of mammalian polyamine oxidase. J Med Chem 1985; 28:1-2 PMID:3965702; http://dx.doi.org/10.1021/jm00379a001
48. Federico R, Leone L, Botta M, Binda C, Angelini R, Venturini G, et al. Inhibition of pig liver and Zea mays L. polyamine oxidase: a comparative study. J Enzyme Inhib 2001; 16:147-55 PMID:11342283; http://dx.doi.org/10.1080/14756360109162364